Membranous nephropathy: A rare renal manifestation of IgG4-related systemic disease

Clinical Nephrology

Volumn 77, Issue 4, 2012, Pages 321-328

  Jindal, Nidhi ^a   Yadav, Dhiraj ^a   Passero, Christopher ^a   Krasinskas, Alyssa ^a   Craig, Fiona ^a   Bastacky, Sheldon ^a   Liang, Kelly V ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Castleman disease; Igg4 disease; Membranous nephropathy; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN G4; PREDNISONE; RITUXIMAB;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; BILE DUCT OBSTRUCTION; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELLULITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIALYSIS; EDEMA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HEMATURIA; HUMAN; HYPOALBUMINEMIA; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED SYSTEMIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; KIDNEY BIOPSY; LEG EDEMA; LIVER FUNCTION TEST; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NAUSEA; PERIPHERAL EDEMA; PLASMA CELL; PROSTATITIS; PROTEINURIA; STENT; WEIGHT REDUCTION;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; BIOPSY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; EARLY DIAGNOSIS; EDEMA; GIANT LYMPH NODE HYPERPLASIA; GLOMERULONEPHRITIS, MEMBRANOUS; GLUCOCORTICOIDS; HEMATURIA; HUMANS; HYPERTENSION; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; KIDNEY FAILURE, CHRONIC; MALE; PREDNISONE; PROSTATIC HYPERPLASIA; PROTEINURIA; RENAL DIALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84861495590     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107037     Document Type: Article

References (43)

1. Takahashi H, Yamamoto M, Suzuki C, Naishiro Y, Shinomura Y, Imai K. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev. 2010; 9: 591-594. doi:10.1016/j.autrev.2010.05.003 PubMed
2. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A, Egawa N, Nakajima H. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003; 38: 982-984. doi:10.1007/s00535-003-1175-y Pub Med
3. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008; 14: 3948-3955. doi:10.3748/wjg.14.3948 PubMed
4. Bateman AC, Deheragoda MG. IgG4-related systemic sclerosing disease-an emerging and under-diagnosed condition. Histopathology. 2009; 55: 373-383. doi:10.1111/j.1365-2559. 20 08. 03217.x PubMed
5. Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006; 41: 613-625. doi:10.1007/s00535-006-1862-6 PubMed
6. Church NI, Pereira SP, Deheragoda MG, Sandanayake N, Amin Z, Lees WR, Gillams A, Rodriguez-Justo M, Novelli M, Seward EW, Hatfield AR, Webster GJ. Autoimmune pancreatitis: clinical and radiological features and objective response to steroid therapy in a UK series. Am J Gastroenterol. 2007; 102: 2417-2425. doi:10.1111/j.1572-0241.2007.01531.x PubMed
7. Watson SJ, Jenkins DA, Bellamy CO. Nephropathy in IgG4-related systemic disease. Am J Surg Pathol. 2006; 30: 1472-1477. doi:10.1097/01. pas.0000213308.43929.97 PubMed
8. Cheuk W, Yuen HK, Chu SY, Chiu EK, Lam LK, Chan JK. Lymphadenopathy of IgG4-related sclerosing disease. Am J Surg Pathol. 2008; 32: 671-681. doi:10.1097/PAS.0b013e318157c068 PubMed
9. Sato Y, Kojima M, Takata K, Morito T, Asaoku H, Takeuchi T, Mizobuchi K, Fujihara M, Kuraoka K, Nakai T, Ichimura K, Tanaka T, Tamura M, Nishikawa Y, Yoshino T. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease. Mod Pathol. 2009; 22: 589-599. doi:10.1038/mod pa thol.2009.17 PubMed
10. Ghazale AH, Chari ST, Vege SS. Update on the diagnosis and treatment of autoimmune pancreatitis. Curr Gastroenterol Rep. 2008; 10: 115-121. doi:10.1007/s11894-008-0031-x PubMed
11. Sánchez-Castañón M, de las Heras-Castaño G, López-Hoyos M. Autoimmune pancreatitis: an underdiagnosed autoimmune disease with clinical, imaging and serological features. Autoimmun Rev. 2010; 9: 237-240. doi:10.1016/j. autrev.2009.07.003 PubMed
12. Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, Petersen BT, Topazian MA, Vege SS. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol. 2009; 7: 1097-1103. doi: 10.1016/j.cgh.2009.04.020 PubMed
13. Sugumar A, Chari ST. Distinguishing pancreatic cancer from autoimmune pancreatitis: a comparison of two strategies. Clin Gastroenterol Hepatol. 2009; 7 (Suppl): S59-S62. doi:10.1016/j. cgh.2009.07.034 PubMed
14. Barth E, Savides TJ. Autoimmune pancreatitis. Expert Rev Clin Immunol. 2009; 5: 801-811. doi:10.1586/eci.09.54 PubMed
15. Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas. 2003; 27: 14-19. doi:10.1097/00006676-200307000-00002 PubMed
16. Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M, Whitcomb DC, Slivka A. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol. 2009; 104: 2295-2306. doi: 10. 1038/ajg.2009.325 PubMed
17. Dhall D, Suriawinata AA, Tang LH, Shia J, Klimstra DS. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010; 41: 643-652. doi:10.1016/j.humpath.2009.10.019 PubMed
18. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol. 2003; 98: 2694-2699. doi:10.1111/j.1572-0241.2003.08 775.x PubMed
19. Uchiyama-Tanaka Y, Mori Y, Kimura T, Sonomura K, Umemura S, Kishimoto N, Nose A, Tokoro T, Kijima Y, Yamahara H, Nagata T, Masaki H, Umeda Y, Okazaki K, Iwasaka T. Acute tubulointerstitial nephritis associated with autoimmunerelated pancreatitis. Am J Kidney Dis. 2004; 43: 18-25. doi:10.1053/j.ajkd. 2003. 12. 006 PubMed
20. Saeki T, Imai N, Ito T, Yamazaki H, Nishi S. Membranous nephropathy associated with IgG4-related systemic disease and without autoimmune pancreatitis. Clin Nephrol. 2009; 71: 173-178. PubMed
21. Yoneda K, Murata K, Katayama K, Ishikawa E, Fuke H, Yamamoto N, Ito K, Shiraki K, Nomura S. Tubulointerstitial nephritis associated with IgG4-related autoimmune disease. Am J Kidney Dis. 2007; 50: 455-462. doi:10.1053/j.ajkd.2007. 05. 018 PubMed
22. Rudmik L, Trpkov K, Nash C, Kinnear S, Falck V, Dushinski J, Dixon E. Autoimmune pancreatitis associated with renal lesions mimicking metastatic tumours. CMAJ. 2006; 175: 367-369. doi:10.1503/cmaj.051668 PubMed
23. Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004; 19: 474-476. doi:10.1093/ndt/gfg477 PubMed
24. Saeki T, Saito A, Yamazaki H, Emura I, Imai N, Ueno M, Nishi S, Miyamura S, Gejyo F. Tubulointerstitial nephritis associated with IgG4-related systemic disease. Clin Exp Nephrol. 2007; 11: 168-173. doi:10.1007/s10157-007-0464-9 PubMed
25. Triantopoulou C, Malachias G, Maniatis P, Anastopoulos J, Siafas I, Papailiou J. Renal lesions associated with autoimmune pancreatitis: CT findings. Acta Radiol. 2010; 51: 702-707. doi:10.3109/02841851003738846 PubMed
26. Morimoto J, Hasegawa Y, Fukushima H, Uesugi N, Hisano S, Saito T, Kaneoka H. Membranoproliferative glomerulonephritis-like glomerular disease and concurrent tubulointerstitial nephritis complicating IgG4-related autoimmune pancreatitis. Intern Med. 2009; 48: 157-162. doi:10.2169/internalmedicine.48.1339 PubMed
27. Katano K, Hayatsu Y, Matsuda T, Miyazaki R, Yamada K, Kawano M, Takahashi N, Kimura H, Yoshida H. Endocapillary proliferative glomerulonephritis with crescent formation and concurrent tubulointerstitial nephritis complicating retroperitoneal fibrosis with a high serum level of IgG4. Clin Nephrol. 2007; 68: 308-314. PubMed
28. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009; 361: 11-21. doi:10.1056/NEJMoa0810457 PubMed
29. Beck LH Jr, Salant DJ. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 2010; 77: 765-770. doi:10.1038/ki.2010.34PubMed
30. Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009; 16: 236-246. doi:10.1097/PAP.0b013e3181a9d4d3 PubMed
31. Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, Castilla C, Blanco OJ, Caballero D, San Miguel JF. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol. 2005; 78: 302-305. doi:10.1002/ajh.20283 PubMed
32. Sugimoto T, Ito J, Takeda N, Gasyu I, Okazaki T, Sakaguchi M, Osawa N, Tanaka Y, Oka K, Uzu T, Kashiwagi A. A case of Castleman's disease complicated with nephrotic syndrome due to glomerulopathy mimicking membranoproliferative glomerulonephritis. Am J Med Sci. 2008; 335: 495-498. doi:10.1097/MAJ.0b013e 31 8 1571f7e PubMed
33. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, Manganaro D, Fasan M, Moroni M, Galli M, Parravicini C. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood. 2001; 98: 3473-3475. doi:10.1182/blood. V98.12.3473 PubMed
34. Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol. 2003; 82: 766-768. doi:10.1007/s00277-003-0718-x PubMed
35. Ide M, Ogawa E, Kasagi K, Kawachi Y, Ogino T. Successful treatment of multicentric Castleman's disease with bilateral orbital tumour using rituximab. Br J Haematol. 2003; 121: 818-819. doi:10.1046/j.1365-2141.2003.04358.x PubMed
36. Ruggenenti P, Cravedi P, Sghirlanzoni MC, Gagliardini E, Conti S, Gaspari F, Marchetti G, Abbate M, Remuzzi G. Effects of rituximab on morphofunctional abnormalities of membranous glomerulopathy. Clin J Am Soc Nephrol. 2008; 3: 1652-1659. doi:10.2215/CJN.01730408 PubMed
37. Johnson PW, Glennie MJ. Rituximab: mechanisms and applications. Br J Cancer. 2001; 85: 1619-1623. doi:10.1054/bjoc.2001.2127 PubMed
38. Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR. A review of the current use of rituximab in autoimmune diseases. Int Immunopharmacol. 2009; 9: 10-25. doi:10.1016/j. intimp.2008.10.004 PubMed
39. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, Stevens RM, Shaw T. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004; 350: 2572-2581. doi:10.1056/NEJMoa032534 PubMed
40. Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with rituximab: report of a case and review of the literature. Rheumatol Int. 2009; 29: 1481-1485. doi:10.1007/s00296-009-0843-5 PubMed
41. Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010; 62: 1755-1762. doi: 10.1002/art.27435 PubMed
42. Topazian M, Witzig TE, Smyrk TC, Pulido JS, Levy MJ, Kamath PS, Chari ST. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2008; 6: 364-366. doi:10.1016/j.cgh.2007.12.020 PubMed
43. Lim L, Suhler EB, Smith JR. Biologic therapies for inflammatory eye disease. Clin Experiment Ophthalmol. 2006; 34: 365-374. doi:10. 11 11/j.1442-9071.2006.01225.x PubMed